Market Trends of Global Caspofungin Industry
This section covers the major market trends shaping the Caspofungin Market according to our research experts:
Candidiasis Segment is Expected to Hold the Major Market Share in the Caspofungin Market
The candidiasis segment is expected to dominate the industry over the forecast period. The lucrative growth of the segment can be attributed to a rise in the prevalence of esophageal candidiasis among men and vaginal yeast infections among women. For example, according to an article published in the Asian Journal of Medical Sciences in October 2021, the prevalence of non-albicans candida was 08.89% in India and was gradually increasing.Similarly, an article published by Journal Metrics in August 2021 indicated that there had been an increase in the number of elderly people affected by oral candidiasis in Brazil. The rising prevalence of candidiasis infection around the world is expected to boost the growth of the studied market over the forecast period.
Also, approval of caspofungin as the first line of treatment for patients with invasive candidiasis who are resistant to other antifungal agents is expected to boost the growth of the market. As per the Infectious Diseases Society of America report, published in February 2020, Candida auris is multidrug-resistant and has emerged as a global health threat. Serious outbreaks of this C. auris can be treated with caspofungin. For example, the Centers for Disease Control and Prevention (CDC) stated in a July 2021 article on Candida auris that caspofungin (70 mg dose) can be used to treat C cruise infection in adults. Thus, increased use of caspofungin to treat various types of Candidiasis, such as intra-abdominal abscesses, peritonitis, and pleural space, in addition to diabetes, is expected to drive segment growth over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period.
North America is expected to dominate the global caspofungin market throughout the forecast period. This dominance is mainly due to rising incidences of vaginal, vulvovaginal, and fungal infections (candidiasis due to changes in lifestyles and a rise in stress. There is an increase in the incidence of candidemia and invasive aspergillosis due to the huge population of geriatrics in the United States. As per the Centers for Disease Control and Prevention (CDC) report published in February 2021, around one-third of patients with advanced HIV infection were affected by candidiasis in the mouth and throat. According to an article on vaginal candidiasis by the same source published in July 2022, an estimated 1.4 million outpatient visits for vaginal candidiasis occur in the United States annually. The region's high prevalence of candidiasis infection is expected to drive the growth of the studied market.
Also, a higher prescription of antibiotics and uncontrolled diabetes in the region are expected to fuel market growth. According to the National Diabetes Statistics Report updated in January 2022, around 37.3 million people in the United States have diabetes, which equates to around 11.3% of the total population. Also, the report stated that around 96 million people aged 18 or older in the United States have prediabetes. The caspofungin derivative products like micafungin may contribute to hypoglycemia in patients, thereby preventing diabetes and thus contributing to the studied market's growth.
Thus, the above-mentioned factors are expected to drive the growth of the studied market.
